Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 10,600 shares, an increase of 15.2% from the March 31st total of 9,200 shares. Based on an average daily trading volume, of […]